News iRhythm digital heart monitoring service backed by NICE A heart monitor developed by iRhythm has become the first product to be endorsed by NICE in a pilot project covering digital health technologies.
Partner Content Partner Content Patient Monitoring Devices Market will grow at 5% CAGR betwe... Patient Monitoring Devices Market worth $27bn by 2025
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.